Difference between revisions of "Smith HA, et al. J. Mol. Med. (2013) cited as Ref 294 in DOI: 10.1038/s41392-020-0110-5 (Q9557)"
Jump to navigation
Jump to search
(Created claim: Second Author string (P150): Kang Y, #quickstatements; #temporary_batch_1589998140706) |
(Created claim: DOI Identifier (P138): 10.1007/s00109-013-1021-5, #quickstatements; #temporary_batch_1590000649558) |
||
| Property / DOI Identifier | |||
| + | |||
| Property / DOI Identifier: 10.1007/s00109-013-1021-5 / rank | |||
| + | Normal rank | ||
Revision as of 18:57, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Smith HA, et al. J. Mol. Med. (2013) cited as Ref 294 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Smith HA
0 references
Kang Y
0 references
